Thoughts.
Watch this space for the latest News, Top Tips, Blogs and Master Classes from Pharmora.
Our latest thinking
News
Current and future treatments for HIV/AIDS, Medical Information (3 of 3)
In this 3rd and final blog of the series, Josh describes the current management of HIV/AIDS, discusses the medicines in development, and provides an insight into the health inequality impacting this condition.
Early treatments, the Stigma and HAART, Medical Information (2 of 3)
In our previous blog, we looked at the initial discovery of HIV, the mechanisms of how it infects CD4 cells and the human cost of the virus in the 1980s. Here, we will discuss the first treatments to become available for HIV, their side effects, the stigma associated with the disease and what that meant for patient prognosis, and the introduction of Highly Active Antiretroviral Therapy (HAART).
Celebrating the 10th Annual Global Campaign for Patient Safety
The much-anticipated MedSafetyWeek - now in its tenth year - is here! This year’s theme, “We can all help make medicines safer,” highlights the collective role we play in ensuring medicine safety. By reporting suspected adverse reactions to medicines and vaccines, and...
Top Tips
Pharmora RMP Masterclass (2): RMP Development Process -TOP TIPS
In this blog our CMO, Dr Stephanie Jones, provides detailed guidance on how to save time and effort and produce high quality risk management plans. Read on to find out more!
IDMC Tips to Help You Prepare
An Independent Data Monitoring Committee (IDMC) is a group of experts contracted to review data during a clinical trial. The members are individuals with ‘extensive clinical experience’ (Sartor et al, 2015) in that area of research, and they are independent of the Sponsor conducting the trial.
Top Tips for CSR Safety Narratives
Whether you are working with an external service provider or creating them in-house the safety narratives always cause a great deal of work right at the end of the study. This can be the busiest period when the team needs to focus on generating key messages for the completed study report (CSR) and potentially a marketing authorisation application.
Blog Posts
Celebrating the 10th Annual Global Campaign for Patient Safety
The much-anticipated MedSafetyWeek - now in its tenth year - is here! This year’s theme, “We can all help make medicines safer,” highlights the collective role we play in ensuring medicine safety. By reporting suspected adverse reactions to medicines and vaccines, and...
Conversations With Industry Leaders : Dr Sheuli Porkess
Dr Jones was delighted to meet with Dr Sheuli Porkess, Director of Actaros Consultancy and President of the Faculty of Pharmaceutical Medicine to talk about some hot topics in our industry! Read on to hear their insights on AI and the challenges of encouraging diversity in our industry…
Hereditary Cancer Awareness Week: Understanding Risk, Empowering Families
Hereditary Cancer Awareness Week raises awareness of inherited cancer risks such as BRCA and Lynch syndrome. Learn how family history, genetic testing, and new research in population screening and polygenic risk scores are shaping the future of cancer prevention.
Case Studies
Unblinded Medical Review (UMR): How does it work in Pharmora?
In a follow up to the blog outlining what unblinded medical review (UMR) means and why it might be needed, this case study from one of the UMR team explains how Pharmora can support with UMR of clinical trial data.
Unblinded Medical Review (UMR): what is it and when is it needed?
In this blog we explain what UMR means and why the Sponsors of clinical trials for investigational medicinal products might need it.
Unexpected Signal Evaluations
Pharmora helped to meet a tight deadline for submitting an application for marketing approval by reviewing multiple signals to support the safety profile.
Master Class
Current and future treatments for HIV/AIDS, Medical Information (3 of 3)
In this 3rd and final blog of the series, Josh describes the current management of HIV/AIDS, discusses the medicines in development, and provides an insight into the health inequality impacting this condition.
Early treatments, the Stigma and HAART, Medical Information (2 of 3)
In our previous blog, we looked at the initial discovery of HIV, the mechanisms of how it infects CD4 cells and the human cost of the virus in the 1980s. Here, we will discuss the first treatments to become available for HIV, their side effects, the stigma associated with the disease and what that meant for patient prognosis, and the introduction of Highly Active Antiretroviral Therapy (HAART).
Immunisation Masterclass (3) HPV Vaccination
As the third blog of the immunisation masterclass series is published on International HPV Awareness Day, Pharmora would like to take this opportunity to highlight the importance of HPV vaccination. Read this blog where we explore HPV and its associated risk, why you need an HPV vaccination, and debunk some common myths around the topic!
